More Evidence to Help Guide Decision Making About Aspirin for Primary Prevention

Ann Intern Med. 2018 Dec 4;169(11):804-805. doi: 10.7326/M18-2637. Epub 2018 Nov 27.

Authors

Michael Pignone¹, Darren A DeWalt²

Affiliations

¹ Dell Medical School, University of Texas, Austin, Texas (M.P.).
² University of North Carolina School of Medicine, Chapel Hill, North Carolina (D.A.D.).

PMID: 30476933
DOI: 10.7326/M18-2637

No abstract available

MeSH terms

Age Factors
Aged
Anti-Inflammatory Agents, Non-Steroidal / adverse effects
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Aspirin / adverse effects
Aspirin / therapeutic use*
Cardiovascular Diseases / prevention & control*
Clinical Decision-Making*
Humans
Middle Aged
Primary Prevention*
Risk Assessment

Substances

Anti-Inflammatory Agents, Non-Steroidal
Aspirin